Sanatan Sanstha’s Saint H.H. (Dr.) Nilakanth Amrut Dikshit renounces body
Sanatan Sanstha’s 87th Saint H.H. (Dr.) Nilakanth Amrut Dikshit (92 years) renounced body at 9.35 p.m. on 27th July 2020 at His home.
Sanatan Sanstha’s 87th Saint H.H. (Dr.) Nilakanth Amrut Dikshit (92 years) renounced body at 9.35 p.m. on 27th July 2020 at His home.
Sanatan Sanstha is carrying out the mission of propagating Dharma selflessly and without expectations for many years. This mission is being carried out ceaselessly by seekers from various places all over India.
Sanatan Sanstha National Spokesperson Mr. Chetan Rajhans when speaking during an online conversation with journalists on July 25, 2020 – on behalf of Sanatan Sanstha and Hindu Janajagruti Samiti on the topic of ‘Growing stress in journalists in the present scenario and solutions to it’.
Readers, well-wishers and devout Hindus who wish to make the solar equipment available for setting up the solar energy project or assist financially may please contact us.
Yoga and meditation, the two ancient Indian remedial methods are found effective to deal with COVID-19, claim International experts.
A Shiv Idol produced out of metal identified as ‘Kalpa Vigrah’ was found in India. It is supposed to be one of the most ancient Idol found so far in the world.
First-ever Hindu lawmaker of the US Tulsi Gabbard said during a virtual commencement address that in this chaotic time when no one can say what tomorrow looks like, one can find certainty, strength and peace in Bhagavad Gita.
On Jyeshtha Amavasya (21.6.2020), Sunday, an annular solar eclipse will be visible in Rajasthan, Punjab, Haryana and part of Uttarakhand and partial solar eclipse in the rest of India around 10 a.m.
The social media is alerting the public and creating panic by circulating messages that as there are 3 eclipses occuring on 5.6.2020, 21.6.2020 and 5.7.2020 respectively, there may be occurance of natural calamities.
A biotech company SAb Biotherapeutics has coaxed genetically modified cows to pump out human antibodies that subdue SARS-CoV-2, the pathogen causing the deadly disease, and it plans to start clinical trials of them this summer.